Skip to main content
Drug Name Eylea Aflibercept
Drug Class
Hematopoietic growth factor
Risk minimization type
Healthcare provider guide
patient guide
Specialty (Theraputic area)
Ophthalmology
Risk

• Endophthalmitis (likely infectious origin)
• Intraocular inflammation
• Transient intraocular pressure increase
• Retinal pigment epithelial tears
• Cataract (especially of traumatic originMedication errors
•  misuse
• Embryo-fetotoxicity

patient guide





Health care provider guide